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Abstract
Introduction: Umbilical cord blood contains relatively abundant primitive CD34+ hematopoietic progenitor cells which can
differentiate into T lymphocytes ex vivo. 
Materials and Methods: In this study, thymic stromal cells (TSCs) were isolated from aborted fetuses and a monolayer cul-
ture system was established. Highly-purified CD34+ cells from umbilical cord blood were cultured on the TSCs after limit-
ing-dilution. The cells were then harvested and evaluated for CD4, CD8, and CD3 expression at different time points.
CD4+CD8–CD3– lymphoid progenitor cells that could differentiate into mature T lymphocytes were observed after 15 days
when a cocktail of cytokines, including Flt-3 ligand, stem cell factor, interleukin (IL)-12, and IL-2, was added. 
Results: These results thus show that CD4+CD8–CD3– cells can be derived from CD34+ cells in vitro when cultured on TSCs. 
Conclusions: We showed that CD4+CD8–CD3– cells can be derived from highly purified CD34+ cells on TSCs during T-cell
lymphopoiesis in vitro.
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INTRODUCTION
Hematopoietic stem cells (HSCs) are capable of
self-renewal and differentiation into erythroid, myeloid,
and lymphoid lineages (Mikkola et al. 2003). T-cell lym-
phopoiesis is largely dependent on the presence of the
thymus (Kakinuma et al. 2003; Sugimoto et al. 2002).
Generally, T-cell precursors migrate into the thymus
from bone marrow and differentiate from CD4–CD8–
cells into mature CD4 or CD8 single-positive cells via
immature CD3–CD4+ single-positive and CD4+CD8+
cell stages (Andersnon et al. 1994; Guidos et al. 1990).
The fate of most developing thymocytes is intrathymic
death, either early through a failure of the surface T-cell
receptor to be engaged by self MHC (positive selection)
or later in a maturation process by which self-reactive
thymocytes are eliminated (negative selection). Only
1–2% of total thymocytes are exported to the periphery
after undergoing positive and negative selection (Deftos
et al. 2000; Kappler et al. 1987; Kraft et al 1993; Su and
Manley 2002; Swat et al. 1992). CD3–CD4–CD8– thymo-
cytes result in the sequential appearance of
CD3–CD4+CD8– and CD3+CD4+CD8+ cells, and
immature CD3–CD4+ single-positive cells are thought
to be mainly located in the outer cortex and to be blas-
tic and cortisone sensitive (Guidos et al. 1990). Kim et
al. (Kim et al. 2005) found that OX40 signals from
CD4+CD3– cells located in the outer T zone select pro-
liferating Th2 effectors into the memory T cell pool.
Lane et al. (Lane et al. 2005) thought that CD4+CD3–
cells have two functions: organizing lymphoid tissue
during development and supporting T-cell help for
B cells both during affinity maturation in germinal cen-
ters and for memory antibody responses. Their further
research showed that CD4+CD3– cells act as a tether
between the selecting T cells and the follicular dendrit-
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ic cells and thus play a role in segregating B and T cells
in normal lymphoid tissue (Kim et al. 2007; Lane et al.
2005). 
The thymic epithelium is essential for the early T-
-cell differentiation of hematopoietic precursors as well
as the terminal differentiation to mature T cells
(Utsuyama et al. 2003). A number of different cell types
in the thymus play critical roles in the process of sup-
porting T-cell differentiation, including MHC class II-
-positive thymic epithelial cells and mesenchymal cells.
In general, T-cell differentiation depends on the com-
plex three-dimensional structure of an intact thymic
environment. However, it is not clear whether the dif-
ferentiation from CD34+ cells toward T cells can be
observed through the immature CD4+CD8–CD3– cells.
The experimental study of human T-cell lym-
phopoiesis has been largely limited to the use of the
OP9 expressing the Notch ligand Delta-like 1 (OP9-
-DL1) SCID-hu mouse model (Galy et al. 1993), murine
and human thymic organ cultures (Rosenzweig et al.
1994; Yeoman et al. 1993), and human thymic monolay-
ers (Poznansky et al. 2000). Zuniga-Pflucker demon-
strated that retrovirally transduced DL1 Notch ligand to
the OP9 bone marrow stromal cell line inhibited the
development of B cells but favored the development of
T cells from fetal liver-derived HSCs and CB-derived
HSCs (La Motte-Mohs et al. 2005). In previous studies,
thymic stromal cell (TSC) monolayer culture systems
provided a useful tool for studying the differentiation of
human T lymphocytes. Umbilical cord blood is an alter-
native source of hematopoietic stem and progenitor
cells. In this study we utilized TSC support systems
which were based on fetal thymus organ culture as
described by Jenkinson et al. (Jenkinson et al. 1982) and
Kingstion et al. (Kingston et al. 1985) to study T-cell dif-
ferentiation from CD34+ cells purified from umbilical
cord blood. The results demonstrated the transient
immature CD4+CD8–CD3– cells could be induced from
CD34+ cells in the presence of TSCs.
MATERIALS AND METHODS
Thymic organ culture
This study protocol was reviewed and approved by
the ethics review committee of our hospital. Human thy-
mus gland was removed from electively aborted fetuses
of 18–20 weeks of gestation by aseptic operation in the
department of Ob/Gyn of our hospital after the moth-
er’s informed consent was obtained. Thymic tissue was
processed within 4 h of harvest. The thymic tissue was
minced into small fragments, passed through a mesh
sieve, and digested into a single-cell suspension by incu-
bation in phosphate-buffered saline (PBS) containing
0.5 mg/ml of collagenase (Sigma, St. Louis, MO, USA)
and 2 U/ml DNase I (Sigma) at 37°C for 60 min with fre-
quent agitation. Typically, 1–10×108 cells were obtained
per gland, with about 90% viability as assessed by trypan
blue exclusion. The cell suspension was then washed twice
in culture media (IMDM; Gibco, Grand Island, NY, USA)
containing 10% heat-inactivated human AB serum (HABS)
and glutamine (1 mM). Thymic stromal cultures were
established using fresh cells in 24-well plates at a concen-
tration of 106 cells per well in 2 ml of medium at 37°C in
a humidified atmosphere of 5% CO2/95% air. After two
day’s culture, non-adherent cells were removed by washing
twice with fresh medium. The monolayer was then incubat-
ed in culture media that was changed at least twice a week.
Adherent cells were detached by trysin-EDTA (Gibco,
Grand Island, NY, USA) after they reached confluence and
seeded at 105 cells/well in 48-well plates (Costar,
Cambridge, MA, USA) with IMDM containing 10%
HABS and glutamine (1 mM). The second-passage TSCs
were used as a feeder layer in the T-cell lymphopoiesis
assay.
Purification of cord blood CD34+ cells
Umbilical cord blood was obtained from the
Department of Ob/Gyn at our hospital after the moth-
er’s informed consent was obtained. Cord blood
(50–100 ml) was collected in sterile bags containing 28
ml of citrate phosphate dextrose (Sigma) as anticoagu-
lant, brought to the laboratory at room temperature,
and processed within 6 h. Mononuclear cells (MNCs)
were separated by density gradient centrifugation at
1300 rpm for 15 min at room temperature over Ficoll-
-Paque (Pharmacia Biotech Inc., Piscataway, NJ, USA).
Interface cells were washed twice by mixing with 2 ml of
buffer-PBS and centrifuging at 1500 rpm for 8 min at
room temperature. The MNCs were resuspended in
complete medium and cultured overnight at 37°C to
remove adherent cells. Erythrocytes were removed by lysis
with 0.15 M ammonium chloride.
Highly purified CD34+ cells were enriched from
MNCs with two rounds of purification. First, MNCs
were incubated with magnetic beads coated with anti-
-human CD34 antibody (QBEND/10, MACS, Bergisch
Gladbach, Germany), then CD34– cells were removed
by washing three times with buffer-PBS in MACS. The
highly purified CD34+ cells were collected according to
the protocol described by the manufacturer. The col-
lected CD34+ cells were again passed through another
column to achieve a higher purity to ensure that the cells
added to the TSCs were derived from CD34+ cells, not
CD34– cells. The human CD34+ cells purified from cord
blood MNCs using Mini-MACS were further depleted
of cells expressing the lymphoid markers CD2 or CD3 to
minimize T-cell contamination.
Limiting dilution and T-cell lymphopoiesis assay
Immature and mature T cells were generated from
the CD34+ cells using the previously established method
of re-seeding subconfluent cultures (Rosenzweig et al.
2001). The purified CD34+ cells were plated on the
adherent TSCs by limiting-dilution analysis, which is
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used to estimate HSC activity. Four dilutions were used,
with three replicate wells for each. A minimum of 50
CD34+ cells per well were plated in 1 ml of IMDM con-
taining 10% HABS, 10 ng/ml recombinant human inter-
leukin-12 (rhIL-12; Perpertech, USA), 30 ng/ml recom-
binant human Flt-3 ligand (rhFL; Perpertech, USA), 50
ng/ml recombinant human stem cell factor (rhSCF;
Perpertech, USA), and 50 IU/ml rhIL-2 (Perpertech,
USA) at 37°C in 5% CO2/95% air. The dilutions were cho-
sen to be maximally informative after two weeks of incu-
bation. The cytokine combination has been shown to pro-
mote CD34+ cell expansion and T-cell differentiation
(Mourcin et al. 2005; Nelson and Willerford 1998). Half of
the medium in each well was removed and replaced with
fresh medium containing cytokines every 3–4 days.
Immunophenotyping of the cultured cells was carried out
with flow cytometry (XL-AD 2517, Beckman-coulter).
The T-cell subpopulation was detected by staining
with fluorescein isothiocyanate (FITC)-labeled mono-
clonal antibody (mAB) against CD4 (CD4 FITC, BD
Pharmingen), phycoerythrin (PE)-labeled mAB against
CD8 (CD8 PE, BD Pharmingen), and phycoerythrin-
cyanine 5 (PC5)-labeled mAB against CD3 (CD3 PC5,
BC Pharmingen) and analyzed by flow cytometry at days
15, 18, 21, 24, 27, and 30 during the culture period. After
being harvested by gentle aspiration and washed twice
in PBS, the cells were stained in a final volume of 100
µl with the above antibodies. The isotype controls used
were IgG1-FITC, IgG1-PE, and IgG1-PerCP, respec-
tively. The stained samples were washed twice in PBS
and flow cytometry analysis was performed immediate-
ly. System II Software or Cofit software was used for
data analysis.
TSCs without CD34+ cells were cultured at the same
time and harvested using trysin-EDTA at day 0 and day
15. These cells were stained with the same procedure
and served as controls for the T-cell lymphopoiesis assay.
Statistical analysis
Comparisons were made using standard statistical
tests. Results are presented as the mean ± standard
deviation (SD). A p value <0.05 was considered signifi-
cant differentiation. CD4+CD8–CD3– cells were com-
pared with other subsets using repeated measures analy-
ses of variance. Statistical analyses were performed
using CHISS (Chinese High Intellectualized Statistical
Software) version 2004.
RESULTS
As reported by others (Sarun et al. 1998), TSCs from
human thymus were isolated as a reliable feeder layer
for T-cell lymphopoiesis in vitro. The TSCs were moni-
tored daily. The cell clones could be seen on day 3 and
Fig. 1. Phenotype analysis of TSCs. TSCs without CD34+ cord blood cells were detached by trysin-EDTA at day 0 and day 15. Cells were
stained with CD3 PC5, CD4 FITC, and CD8 PE mABs. The result showed that the TSCs were negative for CD4, CD8, and CD3, thus
excluding the possible contamination of CD3–CD4+CD8– from TSCs.
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became confluent on day 8. The TSCs were composed
mainly of epithelial cells (60–90%). A typical TSC
looked like a fibroblast. Flow cytometry analysis showed
that the TSCs were negative for CD3, CD4, and CD8
(Fig. 1). 
About 3–6×105 CD34+ cells were isolated from each
cord blood unit and the purity of the isolated CD34+ cells
ranged from 95 to 99%. When the cord blood CD34+ cells
were cultured on a TSC layer in medium supplemented
with IL-12, FL, SCF, and IL-2, they underwent T-cell lym-
phopoiesis in vitro in a manner that recapitulated T-cell
ontogeny in vivo. The cell number increased rapidly. The
cells were harvested at the indicated time points for pheno-
type analysis. After a two-week culture period, mainly
CD4+CD8+ (double-positive) immature T lymphocytes
were detected. At the same time we found a small immature
CD4+CD8–CD3– cell subset (3.78±0.49%) (Fig. 2). Then
the proportion of immature CD4+CD8+ T lymphocytes
decreased with time, coincident with a gradual increase in
mature T lymphocytes (Fig. 3). To confirm that the imma-
ture and mature T cells were derived from cord blood
CD34+ cells, we harvested and stained control TSCs at dif-
ferent time points and could not detect any T cells (either
immature or mature) by flow cytometry analysis. 
DISCUSSION
TSCs have been proven to be a valuable model in the
study of sequential differentiation of murine, chicken,
rhesus, and human thymocytes. In this study we
observed that the highly purified cord blood CD34+
cells differentiated into T cells on TSCs after limiting
dilution following a pattern that mirrors T-cell develop-
ment in vivo. The T cells derived from this culture sys-
tem have the phenotype of mature T cells. We can
exclude the possibility that these T cells are residue
T cells in the cord blood or arise from the TSCs based
on the following facts. Firstly, two rounds of MACS
were performed for the enrichment of CD34+ cells.
Flow cytometry analysis confirmed that the purity of the
CD34 cells was higher than 99% and residue T cells
were less than 1%. Secondly, the number of CD34+ cells
in each well was controlled by limiting dilution. As
Fig. 2. T-lymphocytic phenotype analysis at different time points show T-cell lymphopoiesis in vitro in a manner that recapitulates T-cell
ontogeny in vivo.
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described above, the enriched CD34+ cells contained
almost no CD34– cells. Thirdly, we could not find any
T cells in the control TSC-only culture, thus excluding
the possibility that the immature and mature T cells
might originate from residual mature thymocytes in the
TSCs. Most importantly, this experiment was repeated
a total of five times by different researchers and the
same result was achieved each time.
It was previously reported that T-cell precursors
migrating from the bone marrow can differentiate from
CD4–CD8– cells into mature CD4+ or CD8+ cells via
immature CD3–CD4+ and CD4+8+ cell stages
(Andersnon et al. 1994). Egerton et al. (Egerton et al.
1990) found that many of the mature thymocytes derive
from a small non-dividing cortical thymocyte pool
(CD4+CD8–CD3–), rather than the earliest dividing
CD4+CD8+ blasts, by labeling dividing thymocytes and
their progeny in vivo with [3H]-thymidine. They showed
that one-for-one differentiation from cortical cells by
CD4+CD8–CD3– cells was as important as selective
clonal expansion during T-cell lymphopoiesis. Nanki et
al. (Nanki et al. 1998) used the PCR-ELISA technique
to examine immature CD4+CD8–CD3– T lymphocytes
for their BJ gene repertoires and found the overall BJ
gene repertoire was developed before antigenic selec-
tion, which was then further modified by thymic selec-
tion and peripheral stimulation. 
Our results also demonstrated that human
CD4+CD8–CD3– cells derived from CD34+ cells in vitro
may be an immature subset during T-cell lymphopoiesis.
Kraft et al. (Kraft et al. 1993) described this
CD4+CD8–CD3– cell population, which represents an
alternative intrathymic T-cell precursor, as a monocytic
population. Gardner et al. (Gardner et al. 1998) also
found that after two weeks of culture on a thymic mono-
layer, donor-derived cells maintained the classic pheno-
types of cortical thymocytes (CD4+CD8–CD3– and
CD4+CD8+) in proportions similar to those of fresh
thymic samples. Kelly and Scollay (Kelly and Scollay
1992) examined cells in the peripheral lymph nodes dur-
ing the first week of life to study mature T cells migrat-
ing from the thymus to peripheral lymphoid organs for
their phenotype and function and they found a high pro-
portion of CD4+CD3– cells that diminished rapidly in
proportion to the number of CD3+ cells increasing after
birth. However, they could not determine their origin
and function. Our study provides new evidence that
these CD4+CD8–CD3– cells may arise from CD34+
cells.
Our study demonstrated the kinetics of
CD4+CD8–CD3– cells, CD4+CD8+CD3+ cells, and
CD4/8 single-positive cells during 15 days in culture.
These results suggest that the immature
CD4+CD8–CD3– cells and CD4+CD8+CD3+ cells
develop differently. As Kraft et al. (Kraft et al. 1993)
proposed, the CD4+CD8–CD3– population is a sequen-
tial intermediate between CD3–CD4–CD8– and
CD4+CD8+CD3+. Our result support Kraft’s proposal
as we observed that the proportion of the
CD4+CD8–CD3– subset decreased with time while the
proportions of the CD3+CD4+ or CD3+CD8+ subsets
increased.
The functions of CD4+CD8–CD3– cells are still
unclear, but it is obvious that they are clinically impor-
tant. Sugimoto et al. (Sugimoto et al. 2002) reported
a woman who was diagnosed with monoclonal
CD3–CD4+-associated idiopathic hypereosinophilic
syndrome, and hydroxyurea lessened only the number of
peripheral eosinophils, but not the number of clonal
CD3–CD4+ T lymphocytes. Brugnoni et al. (Brugnoni et
al. 1997) found that purified CD3–CD4+ cells showed
a Th2/Th0 pattern of cytokine production after activa-
tion, secreting high levels of IL-5 and IL-4 but a low
level of interferon-γ . Nasu et al. (Nasu et al 1994)
reported a patient with adult T-cell leukemia in the
smoldering stage with an aberrant phenotype of
CD3–CD4+CD8– and the phenotype of these cells trans-
formed to CD3+CD4+CD8+ after one month as the dis-
ease progressed. Estes et al. (Estes et al. 1993) demon-
strated that CD3–CD4+ cells may be related to the stress
response of the parasite expanded in the spleens and liv-
ers of M. corti-infected animals. Kim et al. (Kim et al.
2006) found that CD4+CD3– accessory cells are distinct
from dendritic cells, T cells, and other lymphocytes by
genetic fingerprint, and neonatal CD4+CD3– cells up-
-regulate both CD30L and OX40L after adoptive trans-
fer into an adult recipient. Their further study show that
CD4+CD3– accessory cells guide the migration of B and
T cells to their respective locations by activating stromal
cells to up-regulate CCR7 and CXCR5 ligands and are
capable of the segregation of lymphocytes into B- and T-
-cell areas (Kim et al. 2007).
In conclusion, we showed that CD4+CD8–CD3– cells
can be derived from highly purified CD34+ cells on
TSCs during T-cell lymphopoiesis in vitro. The charac-
teristics and function of this cell subpopulation deserve
further study.
Fig. 3. Differentiation of CD34+ cord blood cells. During 21 days
of culture, CD34+ cells differentiated mainly into immature
CD4+CD8+ T lymphocytes. At the same time we found a small
immature CD3–CD4+CD8– cell subset (3.78±0.49%). Then the
proportion of CD4+CD8+ and CD3–CD4+CD8– immature T lym-
phocytes decreased with time, coincident with a gradual increase
in mature T lymphocytes.
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